Deep Vein Thrombosis (DVT) Clinical Trials

7 recruiting

Deep Vein Thrombosis (DVT) Trials at a Glance

6 actively recruiting trials for deep vein thrombosis (dvt) are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Changchun, Edgewood, and Hvidovre. Lead sponsors running deep vein thrombosis (dvt) studies include Argon Medical Devices, Hvidovre University Hospital, and Johannes Gutenberg University Mainz.

Browse deep vein thrombosis (dvt) trials by phase

Treatments under study

About Deep Vein Thrombosis (DVT) Clinical Trials

Looking for clinical trials for Deep Vein Thrombosis (DVT)? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Deep Vein Thrombosis (DVT) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Deep Vein Thrombosis (DVT) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting

Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking

Deep Vein Thrombosis (DVT)Venous EmbolismThrombus in the Peripheral Venous Vasculature+1 more
Argon Medical Devices185 enrolled3 locationsNCT07102160
Recruiting

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

Lung Cancer (Diagnosis)Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)
The First Hospital of Jilin University900 enrolled1 locationNCT07439991
Recruiting
Not Applicable

Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DVT-Cph RCT)

Deep Vein Thrombosis (DVT)
Hvidovre University Hospital152 enrolled1 locationNCT06909240
Recruiting

VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE

Pulmonary Embolism (PE)Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)
Johannes Gutenberg University Mainz2,000 enrolled1 locationNCT02156401
Recruiting
Phase 4

Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

SurgeryDeep Vein Thrombosis (DVT)Trauma+1 more
Oregon Health and Science University606 enrolled1 locationNCT02342444
Recruiting

The Butterfly study. A trial assessing acceptability and safety of using a subcutanous catheter to administer enoxaparin (Clexane) in patients requiring long-term therapy for treatment or prevention of blood clots.

Pulmonary Embolism (PE)Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)
Monash Health40 enrolled2 locationsACTRN12622001059752